PGEN Stock Analysis: Buy, Sell, or Hold?
PGEN - Precigen, Inc. Common Stock
$5.40
0.04 (0.75%)
▲
5d:
+13.68%
30d:
+27.36%
90d:
+72.52%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Smart Money Accumulation
None View Scanner →
Strength: 5.6/10
Get Alerted When PGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: PGEN is 11.1% above its trading range ($4.86). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: PGEN is 11.1% above its trading range ($4.86). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.01
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.35
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PGEN is currently trading at $5.40, which is considered extended relative to its 30-day fair value range of $3.84 to $4.86. From a valuation perspective, the stock is trading at a discount (Forward PE: 27.0) compared to its historical average (50.5). Remarkably, the market is currently pricing in an annual earnings decline of 18.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, PGEN is in a strong uptrend. Immediate support is located at $3.70, while resistance sits at $5.59.
Market Sentiment: PGEN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.45 (+130.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PGEN is in a strong uptrend. Immediate support is located at $3.70, while resistance sits at $5.59.
Market Sentiment: PGEN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.45 (+130.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.84 -
$4.86
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
PGEN is technically overbought (RSI 72). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+11.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 130.6% below Wall St target ($12.45)
Trading Range Analysis
30-Day Trading Range
$3.84 -
$4.86
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.70
Resistance Level
$5.59
Current Trend
Strong Uptrend
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.00
Wall Street Target
$12.45
(+130.6%)
Revenue Growth (YoY)
1633.9%
Valuation Discount vs History
-18.9% cheaper
PE vs Historical
27.0 vs 50.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-18.9%
(market-implied from PE analysis)
1-Year Target
$4.86
(-10%)
2-Year Target
$4.37
(-19%)
3-Year Target
$3.94
(-27%)
3-Yr Target (if PE normalizes)
(PE: 27→51)
$7.36
(+36%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 27.0 to 50.5
Stabilization Target:
$10.10
(+87.0%)
PE Expansion Potential:
+87.0%
Share & Embed Analysis
Last updated: June 24, 2026 6:58 PM ET
Data refreshes hourly during market hours. Next update: 7:58 PM
Data refreshes hourly during market hours. Next update: 7:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Randal J Kirk
SELL
4772781 shares
2026-03-30
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 61 BUY |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$32 | 67 BUY |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 61 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 66 BUY |
Advanced PGEN Option Strategies
Professional options setups generated by AI based on today's PGEN price and gamma walls.
